Intravenous immunoglobulin 10%

intravenous immunoglobulin · Kedrion S.p.A.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Intravenous immunoglobulin 10%, covering 2013-03-13 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP) [Phase 3]

See pricing